Selected research
Market Structure
Global Melatonin Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Melatonin Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Melatonin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Melatonin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Melatonin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Melatonin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Melatonin Capsules include Xiuzheng Pharmaceutical, STAD, Hubei Guangji Pharmaceutical, Chuanqi Pharmaceutical, Solgar, Rexall Sundown, Pharmavite, Pfizer and NOW Foods, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Melatonin Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Melatonin Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Melatonin Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Melatonin Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Melatonin Capsules Segment by Company
Xiuzheng Pharmaceutical
STAD
Hubei Guangji Pharmaceutical
Chuanqi Pharmaceutical
Solgar
Rexall Sundown
Pharmavite
Pfizer
NOW Foods
Nature's Bounty
Natrol
Jamieson Vitamins
GNC
Church & Dwight
Biotics Research
Melatonin Capsules Segment by Type
0.30g/Capsule
0.24g/Capsule
0.15g/Capsule
Melatonin Capsules Segment by Application
Hospital
Clinic
Others
Melatonin Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melatonin Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Melatonin Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melatonin Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Melatonin Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melatonin Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Melatonin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Melatonin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.30g/Capsule
- 0.24g/Capsule
- 0.15g/Capsule
Applications
- Hospital
- Clinic
- Others
Companies covered
- Xiuzheng Pharmaceutical
- STAD
- Hubei Guangji Pharmaceutical
- Chuanqi Pharmaceutical
- Solgar
- Rexall Sundown
- Pharmavite
- Pfizer
- NOW Foods
- Nature's Bounty
- Natrol
- Jamieson Vitamins
- GNC
- Church & Dwight
- Biotics Research
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Melatonin Capsules Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Melatonin Capsules Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Melatonin Capsules Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Melatonin Capsules Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Melatonin Capsules Market Dynamics
- 2.1 Melatonin Capsules Industry Trends
- 2.2 Melatonin Capsules Industry Drivers
- 2.3 Melatonin Capsules Industry Opportunities and Challenges
- 2.4 Melatonin Capsules Industry Restraints
3 Melatonin Capsules Market by Manufacturers
- 3.1 Global Melatonin Capsules Revenue by Manufacturers (2021-2026)
- 3.2 Global Melatonin Capsules Sales by Manufacturers (2021-2026)
- 3.3 Global Melatonin Capsules Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Melatonin Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Melatonin Capsules Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Melatonin Capsules Manufacturers, Product Type & Application
- 3.7 Global Melatonin Capsules Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Melatonin Capsules Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Melatonin Capsules Players Market Share by Revenue in 2025
- 3.8.3 2025 Melatonin Capsules Tier 1, Tier 2, and Tier 3
4 Melatonin Capsules Market by Type
- 4.1 Melatonin Capsules Type Introduction
- 4.1.1 0.30g/Capsule
- 4.1.2 0.24g/Capsule
- 4.1.3 0.15g/Capsule
- 4.2 Global Melatonin Capsules Sales by Type
- 4.2.1 Global Melatonin Capsules Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Melatonin Capsules Sales by Type (2021-2032)
- 4.2.3 Global Melatonin Capsules Sales Market Share by Type (2021-2032)
- 4.3 Global Melatonin Capsules Revenue by Type
- 4.3.1 Global Melatonin Capsules Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Melatonin Capsules Revenue by Type (2021-2032)
- 4.3.3 Global Melatonin Capsules Revenue Market Share by Type (2021-2032)
5 Melatonin Capsules Market by Application
- 5.1 Melatonin Capsules Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Melatonin Capsules Sales by Application
- 5.2.1 Global Melatonin Capsules Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Melatonin Capsules Sales by Application (2021-2032)
- 5.2.3 Global Melatonin Capsules Sales Market Share by Application (2021-2032)
- 5.3 Global Melatonin Capsules Revenue by Application
- 5.3.1 Global Melatonin Capsules Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Melatonin Capsules Revenue by Application (2021-2032)
- 5.3.3 Global Melatonin Capsules Revenue Market Share by Application (2021-2032)
6 Global Melatonin Capsules Sales by Region
- 6.1 Global Melatonin Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Melatonin Capsules Sales by Region (2021-2032)
- 6.2.1 Global Melatonin Capsules Sales by Region (2021-2026)
- 6.2.2 Global Melatonin Capsules Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Melatonin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Melatonin Capsules Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Melatonin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Melatonin Capsules Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Melatonin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Melatonin Capsules Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Melatonin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Melatonin Capsules Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Melatonin Capsules Revenue by Region
- 7.1 Global Melatonin Capsules Revenue by Region
- 7.1.1 Global Melatonin Capsules Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Melatonin Capsules Revenue by Region (2021-2026)
- 7.1.3 Global Melatonin Capsules Revenue by Region (2027-2032)
- 7.1.4 Global Melatonin Capsules Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Melatonin Capsules Revenue (2021-2032)
- 7.2.2 North America Melatonin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Melatonin Capsules Revenue (2021-2032)
- 7.3.2 Europe Melatonin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Melatonin Capsules Revenue (2021-2032)
- 7.4.2 Asia-Pacific Melatonin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Melatonin Capsules Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Melatonin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Xiuzheng Pharmaceutical
- 8.1.1 Xiuzheng Pharmaceutical Company Information
- 8.1.2 Xiuzheng Pharmaceutical Business Overview
- 8.1.3 Xiuzheng Pharmaceutical Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Xiuzheng Pharmaceutical Melatonin Capsules Product Portfolio
- 8.1.5 Xiuzheng Pharmaceutical Recent Developments
- 8.2 STAD
- 8.2.1 STAD Company Information
- 8.2.2 STAD Business Overview
- 8.2.3 STAD Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 STAD Melatonin Capsules Product Portfolio
- 8.2.5 STAD Recent Developments
- 8.3 Hubei Guangji Pharmaceutical
- 8.3.1 Hubei Guangji Pharmaceutical Company Information
- 8.3.2 Hubei Guangji Pharmaceutical Business Overview
- 8.3.3 Hubei Guangji Pharmaceutical Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hubei Guangji Pharmaceutical Melatonin Capsules Product Portfolio
- 8.3.5 Hubei Guangji Pharmaceutical Recent Developments
- 8.4 Chuanqi Pharmaceutical
- 8.4.1 Chuanqi Pharmaceutical Company Information
- 8.4.2 Chuanqi Pharmaceutical Business Overview
- 8.4.3 Chuanqi Pharmaceutical Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Chuanqi Pharmaceutical Melatonin Capsules Product Portfolio
- 8.4.5 Chuanqi Pharmaceutical Recent Developments
- 8.5 Solgar
- 8.5.1 Solgar Company Information
- 8.5.2 Solgar Business Overview
- 8.5.3 Solgar Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Solgar Melatonin Capsules Product Portfolio
- 8.5.5 Solgar Recent Developments
- 8.6 Rexall Sundown
- 8.6.1 Rexall Sundown Company Information
- 8.6.2 Rexall Sundown Business Overview
- 8.6.3 Rexall Sundown Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Rexall Sundown Melatonin Capsules Product Portfolio
- 8.6.5 Rexall Sundown Recent Developments
- 8.7 Pharmavite
- 8.7.1 Pharmavite Company Information
- 8.7.2 Pharmavite Business Overview
- 8.7.3 Pharmavite Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Pharmavite Melatonin Capsules Product Portfolio
- 8.7.5 Pharmavite Recent Developments
- 8.8 Pfizer
- 8.8.1 Pfizer Company Information
- 8.8.2 Pfizer Business Overview
- 8.8.3 Pfizer Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pfizer Melatonin Capsules Product Portfolio
- 8.8.5 Pfizer Recent Developments
- 8.9 NOW Foods
- 8.9.1 NOW Foods Company Information
- 8.9.2 NOW Foods Business Overview
- 8.9.3 NOW Foods Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 NOW Foods Melatonin Capsules Product Portfolio
- 8.9.5 NOW Foods Recent Developments
- 8.10 Nature's Bounty
- 8.10.1 Nature's Bounty Company Information
- 8.10.2 Nature's Bounty Business Overview
- 8.10.3 Nature's Bounty Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Nature's Bounty Melatonin Capsules Product Portfolio
- 8.10.5 Nature's Bounty Recent Developments
- 8.11 Natrol
- 8.11.1 Natrol Company Information
- 8.11.2 Natrol Business Overview
- 8.11.3 Natrol Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Natrol Melatonin Capsules Product Portfolio
- 8.11.5 Natrol Recent Developments
- 8.12 Jamieson Vitamins
- 8.12.1 Jamieson Vitamins Company Information
- 8.12.2 Jamieson Vitamins Business Overview
- 8.12.3 Jamieson Vitamins Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Jamieson Vitamins Melatonin Capsules Product Portfolio
- 8.12.5 Jamieson Vitamins Recent Developments
- 8.13 GNC
- 8.13.1 GNC Company Information
- 8.13.2 GNC Business Overview
- 8.13.3 GNC Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 GNC Melatonin Capsules Product Portfolio
- 8.13.5 GNC Recent Developments
- 8.14 Church & Dwight
- 8.14.1 Church & Dwight Company Information
- 8.14.2 Church & Dwight Business Overview
- 8.14.3 Church & Dwight Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Church & Dwight Melatonin Capsules Product Portfolio
- 8.14.5 Church & Dwight Recent Developments
- 8.15 Biotics Research
- 8.15.1 Biotics Research Company Information
- 8.15.2 Biotics Research Business Overview
- 8.15.3 Biotics Research Melatonin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Biotics Research Melatonin Capsules Product Portfolio
- 8.15.5 Biotics Research Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Melatonin Capsules Value Chain Analysis
- 9.1.1 Melatonin Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Melatonin Capsules Production Mode & Process
- 9.2 Melatonin Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Melatonin Capsules Distributors
- 9.2.3 Melatonin Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst